Metamizole - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Metamizole-containing medicines: important measures to minimise the serious outcomes of known risk of agranulocytosis

Dissemination date: 03/12/2024

Key facts

• Active substance:
  metamizole
• Procedure number:
  EMEA/H/A-107i/1537
• Regulatory outcome:
  Variation
• DHPC type:
  Adverse event
• Dissemination date:
  03/12/2024
• Related medicines:
  Metamizole-containing medicinal products